Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group (Q72667228)
Jump to navigation
Jump to search
scientific article published on 01 March 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group |
scientific article published on 01 March 1994 |
Statements
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group (English)
S L Spruance
A T Pavia
D Peterson
A Berry
R Pollard
T F Patterson
I Frank
S C Remick
M Thompson
R D MacArthur
G E Morey
C H Ramirez-Ronda
B M Bernstein
D E Sweet
L Crane
E A Peterson
C T Pachucki
S L Green
J Brand
A Rios
L M Dunkle
A Cross
M J Brown
P Ingraham
R Gugliotti
A H Schindzielorz